What we are learning

We have known from the beginning that this brouhaha over the “high” out of pocket cost of insulin was an issue that was being somewhat blown out of proportion. To fully appreciate this take a look at the recent decision by Cigna to limit co-pays for insulin to just $25 per month. Per a post on the CNBC web site;

“Health insurer Cigna is lowering the out-of-pocket cost of insulin for some of its members with diabetes, launching a new program next year that caps copays at $25 for a 30-day supply of the drug.

The . . .

This content is restricted to subscribers. Please subscribe.

Already have an account? Please login.